Baxter to Divest Vantive Kidney Care to the Carlyle Group for $3.8B
Pending regulatory approval, this transfer to a global investment company will take place in late 2024 or early 2025. Baxter will use the proceeds to pay down debt.
Read the full article » | Posted 08-16-2024
Related Articles
- Assisted Home HD in Qatar Avoids Ambulance Transport in Vulnerable Patients Posted 08-16-2024
- Dialysis Amid the Rockets (A New Approach to Kidney Failure) Posted 08-16-2024
- ETC Model Structure Did Not Move the Needle on Home Dialysis with Social Risk Factors Posted 07-12-2024
- FDA Class I Recalls of Dialysis Products for Potential Risk of Serious Injury or Death Posted 05-09-2024